Hansilla Alaigh is the Founder and CEO of Global Action Alliance, an AI tech company pioneering the next generation of strategic intelligence. With 14+ years in biotech and pharma leadership, she drives R&D strategy and stakeholder management across medical devices, vaccines, and therapeutics, collaborating with government and non-government agencies globally. Her expertise spans from target identification through commercialization in biotech, large pharma, and non-profits. Hansilla holds a B.S. in Biochemistry and Neuroscience from the University of Surrey, attended Harvard Medical School, earned an M.S. in Systems Engineering from Cornell University, and is currently pursuing a Post Graduate Diploma in AI and Machine Learning from Columbia University.
